Sumitomo Mitsui Trust Group
BNR

Sumitomo Mitsui Trust Group’s Burning Rock Biotech BNR Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
29,724
-413
-1% -$5.85K ﹤0.01% 1049
2026
Q1 		$486K Sell
30,137
-1,670
-5% -$43.7K ﹤0.01% 937
2025
Q4 		$641K Sell
31,807
-3,035
-9% -$44.3K ﹤0.01% 907
2025
Q3 		$301K Sell
34,842
-9,086
-21% -$65.1K ﹤0.01% 1012
2025
Q2 		$139K Hold
43,928
– – ﹤0.01% 1027
2025
Q1 		$198K Sell
43,928
-7,711
-15% -$48.2K ﹤0.01% 1016
2024
Q4 		$349K Sell
51,639
-2,664
-5% -$12.3K ﹤0.01% 983
2024
Q3 		$177K Sell
54,303
-1,943
-3% -$10.7K ﹤0.01% 1044
2024
Q2 		$363K Sell
56,246
-2,897
-5% -$22.1K ﹤0.01% 995
2024
Q1 		$431K Sell
59,143
-7,564
-11% -$63.1K ﹤0.01% 1032
2023
Q4 		$620K Hold
66,707
– – ﹤0.01% 1025
2023
Q3 		$647K Hold
66,707
– – ﹤0.01% 1024
2023
Q2 		$1.43M Buy
66,707
+741
+1% +$19.7K ﹤0.01% 963
2023
Q1 		$1.85M Sell
65,966
-5,437
-8% -$163K ﹤0.01% 919
2022
Q4 		$1.61M Sell
71,403
-2,780
-4% -$63.4K ﹤0.01% 960
2022
Q3 		$1.77M Sell
74,183
-1,117
-1% -$36K ﹤0.01% 956
2022
Q2 		$2.19M Sell
75,300
-137,351
-65% -$6.13M ﹤0.01% 937
2022
Q1 		$19.8M Buy
212,651
+95,397
+81% +$8.29M 0.01% 733
2021
Q4 		$11.2M Buy
117,254
+15,320
+15% +$2.1M 0.01% 763
2021
Q3 		$18.2M Buy
101,934
+15,277
+18% +$3.4M 0.01% 728
2021
Q2 		$25.5M Buy
86,657
+323
+0.4% +$95.6K 0.02% 694
2021
Q1 		$23.2M Buy
86,334
+46,205
+115% +$14.1M 0.01% 695
2020
Q4 		$9.27M Buy
+40,129
New +$10.8M 0.01% 781

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CL
CRCM LP San Francisco, California $152M AUM 26.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AIP
Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

Sumitomo Mitsui Trust Group's BNR Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Burning Rock Biotech (BNR) stake by 1.4% in Q2 2026, selling an estimated $5.85K and leaving 29,724 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Sumitomo Mitsui Trust Group first reported a position in BNR in Q4 2020 and has held it in 23 quarters since. The position peaked at $25.5M in Q2 2021. 17 funds tracked by Wall St. Rank hold BNR as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 29,724 shares of Burning Rock Biotech worth $249K as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 413 Burning Rock Biotech shares in Q2 2026, an estimated $5.85K.
  • Burning Rock Biotech made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #1049 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Burning Rock Biotech in Q4 2020 and has held it in 23 quarters since.
  • Sumitomo Mitsui Trust Group's Burning Rock Biotech position peaked at $25.5M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.